Publications by authors named "H Janssen"

Claim this Profile
T
Tenofovir alafenamide for prevention of HBV reactivation in HBsAg-negative, anti-HBc-positive patients undergoing rituximab-based chemotherapy: A multicenter randomized controlled trial.
Sanam Tabataba Vakili, Grishma Hirode, Atif Zahoor, Ahreni Saunthar, Joshua B Feld, Harry L A Janssen

Hepatol Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight Change is Associated With Metabolic Liver Health in a General Population Extending Beyond Weight Loss Targets of International Guidelines.
Laurens A van Kleef, Mesut Savas, Maurice Michel, Cyrielle Caussy, Jesse Pustjens, Harry L A Janssen

Gastro Hep Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world study.
Maria C van Hooff, Rozanne C de Veer, Ellen Werner, Ulrich Beuers, Joost P H Drenth, Harry L A Janssen

Am J Gastroenterol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualizing endpoints in chronic HBV treatment: HBsAg loss and beyond.
Milan J Sonneveld, Harry L A Janssen

J Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RhoGEF Trio regulates the formation of tensile linear endothelial junctions to improve barrier function.
Jos van Rijssel, Thijs J Sluiter, Jeffrey M A van der Krogt, Cindy I Bart, Juan Zhang, Hans Janssen

Mol Biol Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis